| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Oxygen Consumption | 7 | 2019 | 711 | 2.21 | Why? |
| Adaptation, Physiological | 5 | 2019 | 359 | 1.86 | Why? |
| Carotid Body | 2 | 2018 | 15 | 1.43 | Why? |
| Running | 5 | 2019 | 153 | 1.43 | Why? |
| Exercise | 13 | 2019 | 6771 | 1.42 | Why? |
| Body Temperature Regulation | 2 | 2018 | 31 | 1.41 | Why? |
| Vasodilation | 4 | 2019 | 258 | 1.35 | Why? |
| Sympathetic Nervous System | 7 | 2018 | 111 | 1.26 | Why? |
| Baroreflex | 4 | 2018 | 54 | 1.23 | Why? |
| Physical Endurance | 3 | 2019 | 107 | 1.21 | Why? |
| Cardiorespiratory Fitness | 2 | 2018 | 313 | 1.05 | Why? |
| Hypoxia | 6 | 2018 | 3626 | 0.83 | Why? |
| Homeostasis | 3 | 2019 | 582 | 0.82 | Why? |
| Lower Body Negative Pressure | 2 | 2018 | 3 | 0.81 | Why? |
| Immunization, Passive | 20 | 2021 | 10067 | 0.81 | Why? |
| Autonomic Nervous System | 3 | 2019 | 148 | 0.80 | Why? |
| Nitric Oxide | 3 | 2018 | 769 | 0.79 | Why? |
| Diet, Reducing | 1 | 2018 | 38 | 0.76 | Why? |
| Cell Hypoxia | 1 | 2019 | 141 | 0.74 | Why? |
| Hypovolemia | 1 | 2019 | 65 | 0.74 | Why? |
| Shock, Hemorrhagic | 1 | 2019 | 81 | 0.73 | Why? |
| Physical Exertion | 2 | 2019 | 176 | 0.72 | Why? |
| Blood Pressure | 9 | 2018 | 2198 | 0.71 | Why? |
| Human Genetics | 1 | 2018 | 21 | 0.71 | Why? |
| Bed Rest | 1 | 2017 | 22 | 0.71 | Why? |
| Physical Conditioning, Human | 1 | 2018 | 57 | 0.70 | Why? |
| Cerebrovascular Circulation | 2 | 2018 | 340 | 0.69 | Why? |
| Caffeine | 1 | 2018 | 67 | 0.68 | Why? |
| Precision Medicine | 2 | 2018 | 1477 | 0.68 | Why? |
| Muscle Fatigue | 1 | 2016 | 25 | 0.67 | Why? |
| Plasma | 4 | 2021 | 1809 | 0.67 | Why? |
| Glucose | 3 | 2019 | 573 | 0.67 | Why? |
| Dopamine | 1 | 2017 | 123 | 0.66 | Why? |
| Anticholesteremic Agents | 1 | 2019 | 186 | 0.64 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.62 | Why? |
| Cholesterol | 1 | 2019 | 660 | 0.55 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.55 | Why? |
| Gonadal Steroid Hormones | 1 | 2017 | 328 | 0.54 | Why? |
| Vasoconstriction | 3 | 2017 | 153 | 0.54 | Why? |
| Heart Rate | 6 | 2018 | 1527 | 0.54 | Why? |
| Pulmonary Ventilation | 4 | 2019 | 152 | 0.50 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.49 | Why? |
| Muscle, Skeletal | 5 | 2019 | 915 | 0.46 | Why? |
| Metabolic Syndrome | 1 | 2019 | 810 | 0.43 | Why? |
| Hypoglycemia | 1 | 2015 | 406 | 0.42 | Why? |
| Depressive Disorder, Major | 1 | 2019 | 852 | 0.39 | Why? |
| Blood Glucose | 4 | 2018 | 3642 | 0.39 | Why? |
| Receptors, Adrenergic, alpha | 2 | 2006 | 2 | 0.34 | Why? |
| Postmenopause | 3 | 2017 | 160 | 0.34 | Why? |
| Regional Blood Flow | 4 | 2019 | 172 | 0.33 | Why? |
| Biomedical Research | 2 | 2018 | 5270 | 0.32 | Why? |
| Aging | 4 | 2017 | 3581 | 0.32 | Why? |
| Endothelium, Vascular | 1 | 2018 | 1751 | 0.31 | Why? |
| Diet | 1 | 2019 | 2052 | 0.31 | Why? |
| Fatigue | 1 | 2016 | 2479 | 0.30 | Why? |
| Oxygen | 1 | 2019 | 3715 | 0.29 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.29 | Why? |
| Energy Metabolism | 2 | 2019 | 451 | 0.26 | Why? |
| Norepinephrine | 3 | 2017 | 152 | 0.26 | Why? |
| Body Composition | 2 | 2017 | 414 | 0.26 | Why? |
| Humans | 70 | 2021 | 930598 | 0.25 | Why? |
| Forearm | 4 | 2017 | 52 | 0.24 | Why? |
| Heart | 2 | 2010 | 1791 | 0.24 | Why? |
| Safety | 2 | 2020 | 1583 | 0.24 | Why? |
| Insulin | 4 | 2019 | 1316 | 0.23 | Why? |
| Sympathectomy | 1 | 2002 | 67 | 0.22 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.21 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2015 | 1969 | 0.21 | Why? |
| Antigenic Variation | 1 | 2021 | 249 | 0.21 | Why? |
| Brachial Artery | 2 | 2018 | 107 | 0.21 | Why? |
| Transfusion-Related Acute Lung Injury | 1 | 2020 | 63 | 0.21 | Why? |
| Hemodynamics | 4 | 2017 | 1562 | 0.21 | Why? |
| Aerobiosis | 1 | 2019 | 12 | 0.20 | Why? |
| Blood Flow Velocity | 2 | 2018 | 193 | 0.20 | Why? |
| Exsanguination | 1 | 2019 | 9 | 0.20 | Why? |
| Action Potentials | 2 | 2018 | 368 | 0.20 | Why? |
| Skiing | 1 | 2019 | 19 | 0.20 | Why? |
| Menopause | 2 | 2018 | 136 | 0.20 | Why? |
| Receptors, Adrenergic, beta-1 | 1 | 2018 | 4 | 0.20 | Why? |
| Sympathetic Fibers, Postganglionic | 1 | 2018 | 2 | 0.19 | Why? |
| Parasympathetic Nervous System | 1 | 2018 | 16 | 0.19 | Why? |
| Acid-Base Equilibrium | 1 | 2019 | 53 | 0.19 | Why? |
| Jews | 1 | 2021 | 117 | 0.19 | Why? |
| Lactates | 1 | 2019 | 59 | 0.19 | Why? |
| Twin Studies as Topic | 1 | 2018 | 9 | 0.19 | Why? |
| Cardiac Output | 2 | 2019 | 183 | 0.19 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.19 | Why? |
| Hockey | 1 | 2019 | 31 | 0.19 | Why? |
| Hot Flashes | 1 | 2018 | 20 | 0.19 | Why? |
| Blood Donors | 3 | 2021 | 2956 | 0.19 | Why? |
| Sweat Glands | 1 | 2018 | 16 | 0.19 | Why? |
| Human Genome Project | 1 | 2018 | 20 | 0.18 | Why? |
| Bone Resorption | 1 | 2018 | 61 | 0.18 | Why? |
| Isometric Contraction | 1 | 2017 | 19 | 0.18 | Why? |
| Hyperinsulinism | 1 | 2018 | 27 | 0.18 | Why? |
| Culturally Competent Care | 1 | 2021 | 169 | 0.18 | Why? |
| Epinephrine | 2 | 2017 | 323 | 0.18 | Why? |
| Glycolysis | 1 | 2019 | 208 | 0.18 | Why? |
| Models, Cardiovascular | 1 | 2019 | 153 | 0.18 | Why? |
| Adult | 27 | 2021 | 244371 | 0.18 | Why? |
| Prostaglandins | 1 | 2017 | 21 | 0.18 | Why? |
| Myoglobin | 1 | 2019 | 143 | 0.18 | Why? |
| Postprandial Period | 1 | 2017 | 45 | 0.18 | Why? |
| Transfusion Reaction | 1 | 2020 | 245 | 0.18 | Why? |
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 29 | 0.17 | Why? |
| Exercise Tolerance | 3 | 2018 | 634 | 0.17 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.17 | Why? |
| Metabolism | 1 | 2018 | 74 | 0.17 | Why? |
| Holidays | 1 | 2021 | 311 | 0.17 | Why? |
| Brain Concussion | 1 | 2019 | 113 | 0.17 | Why? |
| Luteinizing Hormone | 1 | 2017 | 91 | 0.17 | Why? |
| Bicycling | 1 | 2019 | 133 | 0.17 | Why? |
| Genetics, Population | 1 | 2018 | 162 | 0.17 | Why? |
| Liver Failure, Acute | 1 | 2021 | 279 | 0.17 | Why? |
| Sodium-Potassium-Exchanging ATPase | 1 | 2017 | 46 | 0.17 | Why? |
| Female | 33 | 2021 | 380317 | 0.17 | Why? |
| Adrenocorticotropic Hormone | 1 | 2017 | 107 | 0.17 | Why? |
| Male | 28 | 2021 | 367725 | 0.17 | Why? |
| Space Flight | 1 | 2017 | 37 | 0.17 | Why? |
| Middle Cerebral Artery | 1 | 2017 | 128 | 0.17 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2021 | 368 | 0.16 | Why? |
| Peripheral Nerves | 1 | 2017 | 74 | 0.16 | Why? |
| Physiology | 1 | 2017 | 62 | 0.16 | Why? |
| Nitroprusside | 2 | 2018 | 18 | 0.16 | Why? |
| Phenylephrine | 2 | 2018 | 20 | 0.16 | Why? |
| Antibody Specificity | 1 | 2021 | 1328 | 0.16 | Why? |
| Athletic Injuries | 1 | 2019 | 208 | 0.16 | Why? |
| Athletic Performance | 1 | 2019 | 208 | 0.16 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.15 | Why? |
| United States Food and Drug Administration | 2 | 2020 | 1276 | 0.15 | Why? |
| Thinking | 1 | 2017 | 105 | 0.15 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.15 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.15 | Why? |
| Coronavirus Infections | 9 | 2021 | 253789 | 0.15 | Why? |
| United States | 7 | 2021 | 46150 | 0.15 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.15 | Why? |
| Young Adult | 12 | 2021 | 93724 | 0.15 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2020 | 694 | 0.15 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.14 | Why? |
| Trimethaphan | 3 | 2018 | 4 | 0.14 | Why? |
| Adenosine Triphosphate | 1 | 2017 | 294 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.14 | Why? |
| Microcirculation | 1 | 2019 | 447 | 0.14 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.13 | Why? |
| Leukoencephalopathies | 1 | 2017 | 230 | 0.13 | Why? |
| Healthy Lifestyle | 1 | 2018 | 447 | 0.13 | Why? |
| Selection, Genetic | 1 | 2018 | 691 | 0.13 | Why? |
| Time-to-Treatment | 2 | 2021 | 5883 | 0.13 | Why? |
| Spleen | 1 | 2018 | 877 | 0.13 | Why? |
| White Matter | 1 | 2017 | 369 | 0.13 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.13 | Why? |
| Hemoglobins | 1 | 2019 | 958 | 0.12 | Why? |
| Terminology as Topic | 1 | 2018 | 546 | 0.12 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.12 | Why? |
| Problem-Based Learning | 1 | 2017 | 363 | 0.12 | Why? |
| Biological Evolution | 1 | 2018 | 641 | 0.12 | Why? |
| Vascular Resistance | 2 | 2017 | 148 | 0.11 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.11 | Why? |
| Pre-Eclampsia | 1 | 2017 | 599 | 0.11 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.11 | Why? |
| Vasodilator Agents | 3 | 2018 | 344 | 0.10 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.10 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.10 | Why? |
| Animals | 6 | 2019 | 78931 | 0.10 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.10 | Why? |
| Minority Groups | 1 | 2021 | 1631 | 0.10 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.10 | Why? |
| Tissue and Organ Procurement | 1 | 2020 | 1277 | 0.10 | Why? |
| Skin | 1 | 2002 | 2096 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.10 | Why? |
| Aged | 11 | 2021 | 215776 | 0.10 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.10 | Why? |
| Ganglionic Blockers | 2 | 2018 | 3 | 0.09 | Why? |
| Peroneal Nerve | 2 | 2018 | 13 | 0.09 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Sports | 1 | 2016 | 690 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Oxidative Stress | 1 | 2019 | 2050 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.09 | Why? |
| Tyramine | 1 | 2006 | 1 | 0.08 | Why? |
| Heart Transplantation | 1 | 2018 | 1293 | 0.08 | Why? |
| Adrenergic Uptake Inhibitors | 1 | 2006 | 11 | 0.08 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.08 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Bariatric Surgery | 1 | 2017 | 1298 | 0.08 | Why? |
| Reference Values | 2 | 2017 | 795 | 0.08 | Why? |
| Sex Factors | 2 | 2017 | 11014 | 0.08 | Why? |
| Catecholamines | 1 | 2006 | 66 | 0.08 | Why? |
| Hyperemia | 1 | 2006 | 62 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.08 | Why? |
| Body Mass Index | 3 | 2017 | 4306 | 0.08 | Why? |
| Liver Transplantation | 1 | 2021 | 2864 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Adrenergic Agonists | 1 | 2002 | 4 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Time Factors | 4 | 2018 | 31397 | 0.06 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.06 | Why? |
| Hyperhidrosis | 1 | 2002 | 17 | 0.06 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.06 | Why? |
| Blood Gas Analysis | 1 | 2006 | 893 | 0.06 | Why? |
| Blood Coagulation Factor Inhibitors | 1 | 2021 | 41 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Veins | 1 | 2002 | 168 | 0.06 | Why? |
| Oximetry | 1 | 2006 | 658 | 0.05 | Why? |
| Respiratory Physiological Phenomena | 1 | 2002 | 157 | 0.05 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Leg | 1 | 2002 | 142 | 0.05 | Why? |
| Investigational New Drug Application | 1 | 2020 | 75 | 0.05 | Why? |
| Judaism | 1 | 2021 | 45 | 0.05 | Why? |
| Registries | 1 | 2021 | 12327 | 0.05 | Why? |
| Athletes | 2 | 2019 | 1047 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Perfusion | 1 | 2020 | 254 | 0.05 | Why? |
| Blood Coagulation Factors | 1 | 2021 | 223 | 0.05 | Why? |
| Receptors, Adrenergic, beta-3 | 1 | 2018 | 10 | 0.05 | Why? |
| Recruitment, Neurophysiological | 1 | 2018 | 9 | 0.05 | Why? |
| Students | 1 | 2017 | 5255 | 0.05 | Why? |
| Connecticut | 1 | 2021 | 547 | 0.05 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2019 | 70 | 0.05 | Why? |
| New Jersey | 1 | 2021 | 528 | 0.05 | Why? |
| Collagen Type I | 1 | 2018 | 56 | 0.05 | Why? |
| Pressoreceptors | 1 | 2018 | 11 | 0.05 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2018 | 32 | 0.05 | Why? |
| Glucose Clamp Technique | 1 | 2018 | 39 | 0.05 | Why? |
| Minnesota | 1 | 2020 | 509 | 0.05 | Why? |
| Youth Sports | 1 | 2019 | 45 | 0.05 | Why? |
| Endothelium | 1 | 2002 | 460 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Afferent Pathways | 1 | 2017 | 7 | 0.04 | Why? |
| Autonomic Agents | 1 | 2017 | 1 | 0.04 | Why? |
| Neural Inhibition | 1 | 2017 | 19 | 0.04 | Why? |
| Biological Transport | 1 | 2019 | 290 | 0.04 | Why? |
| Pregnancy | 2 | 2017 | 23879 | 0.04 | Why? |
| Calorimetry, Indirect | 1 | 2017 | 49 | 0.04 | Why? |
| Propranolol | 1 | 2017 | 36 | 0.04 | Why? |
| Injections, Spinal | 1 | 2017 | 61 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Premenopause | 1 | 2017 | 63 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 143 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Muscle Strength | 1 | 2018 | 317 | 0.04 | Why? |
| Glucose Tolerance Test | 1 | 2017 | 238 | 0.04 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Fentanyl | 1 | 2017 | 142 | 0.04 | Why? |
| Models, Immunological | 1 | 2021 | 727 | 0.04 | Why? |
| Medical History Taking | 1 | 2017 | 350 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.04 | Why? |
| Sports Medicine | 1 | 2019 | 237 | 0.04 | Why? |
| Exercise Test | 2 | 2017 | 911 | 0.04 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Extracellular Vesicles | 1 | 2021 | 607 | 0.03 | Why? |
| Depression | 1 | 2019 | 14116 | 0.03 | Why? |
| California | 1 | 2021 | 2047 | 0.03 | Why? |
| Hot Temperature | 1 | 2002 | 1299 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.03 | Why? |
| Thorax | 1 | 2002 | 1873 | 0.03 | Why? |
| Neurons | 1 | 2018 | 864 | 0.03 | Why? |
| Electrocardiography | 1 | 2006 | 3957 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Fasting | 1 | 2017 | 555 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Lung | 2 | 2018 | 31049 | 0.03 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.03 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Sleep Apnea, Obstructive | 1 | 2017 | 668 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2019 | 9893 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.02 | Why? |
| Elasticity | 1 | 2002 | 70 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.02 | Why? |
| Neurosecretory Systems | 1 | 2002 | 48 | 0.01 | Why? |
| Lung Volume Measurements | 1 | 2002 | 115 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Immobilization | 1 | 2002 | 74 | 0.01 | Why? |
| Respiratory Muscles | 1 | 2002 | 116 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Pressure | 1 | 2002 | 289 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Pulmonary Gas Exchange | 1 | 2002 | 414 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Respiratory Mechanics | 1 | 2002 | 585 | 0.01 | Why? |
| Respiration | 1 | 2002 | 729 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |